Trial
NCT00285779
Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
Wright State University; Tufts Medical Center; University of Louisville; Wake Forest University Health Sciences; University of Michigan; Emory University; University Hospitals Cleveland Medical Center; Icahn School of Medicine at Mount Sinai; Oregon Health and Science University; The Cleveland Clinic; Fivenson, David, M.D.
Condition
Lichen Planus
Intervention
Etanercept
Why stopped
Slow recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-21